Literature DB >> 17641661

Antigen receptor diversification and chromosome translocations.

Mila Jankovic1, André Nussenzweig, Michel C Nussenzweig.   

Abstract

Double-stranded DNA breaks (DSBs) can result in chromosomal abnormalities, including deletions, translocations and aneuploidy, which can promote neoplastic transformation. DSBs arise accidentally during DNA replication and can be induced by environmental factors such as ultraviolet light or ionizing radiation, and they are generated during antigen receptor-diversification reactions in lymphocytes. Cellular pathways that maintain genomic integrity use sophisticated mechanisms that recognize and repair all DSBs regardless of their origin. Such pathways, along with DNA-damage checkpoints, ensure that either the damage is properly repaired or cells with damaged DNA are eliminated. Here we review how impaired DNA-repair or DNA-damage checkpoints can lead to genetic instability and predispose lymphocytes undergoing diversification of antigen receptor genes to malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641661     DOI: 10.1038/ni1498

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  29 in total

Review 1.  Origin of chromosomal translocations in lymphoid cancer.

Authors:  André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

2.  RAP80 protein is important for genomic stability and is required for stabilizing BRCA1-A complex at DNA damage sites in vivo.

Authors:  Jiaxue Wu; Chao Liu; Junjie Chen; Xiaochun Yu
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

Review 3.  DNA damage and repair during lymphoid development: antigen receptor diversity, genomic integrity and lymphomagenesis.

Authors:  Nahum Puebla-Osorio; Chengming Zhu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  53BP1 Contributes to Igh Locus Chromatin Topology during Class Switch Recombination.

Authors:  Scott Feldman; Robert Wuerffel; Ikbel Achour; Lili Wang; Phillip B Carpenter; Amy L Kenter
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

5.  Defective nonhomologous end joining blocks B-cell development in FLT3/ITD mice.

Authors:  Li Li; Li Zhang; Jinshui Fan; Kathleen Greenberg; Stephen Desiderio; Feyruz V Rassool; Donald Small
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

6.  Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.

Authors:  Erin R P Shull; Youngsoo Lee; Hironobu Nakane; Travis H Stracker; Jingfeng Zhao; Helen R Russell; John H J Petrini; Peter J McKinnon
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

7.  AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.

Authors:  Davide F Robbiani; Anne Bothmer; Elsa Callen; Bernardo Reina-San-Martin; Yair Dorsett; Simone Difilippantonio; Daniel J Bolland; Hua Tang Chen; Anne E Corcoran; André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

8.  53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination.

Authors:  Anne Bothmer; Davide F Robbiani; Niklas Feldhahn; Anna Gazumyan; Andre Nussenzweig; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

9.  IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism.

Authors:  Dimitra Zotos; Jonathan M Coquet; Yang Zhang; Amanda Light; Kathy D'Costa; Axel Kallies; Lynn M Corcoran; Dale I Godfrey; Kai-Michael Toellner; Mark J Smyth; Stephen L Nutt; David M Tarlinton
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

10.  AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.

Authors:  Davide F Robbiani; Samuel Bunting; Niklas Feldhahn; Anne Bothmer; Jordi Camps; Stephanie Deroubaix; Kevin M McBride; Isaac A Klein; Gary Stone; Thomas R Eisenreich; Thomas Ried; André Nussenzweig; Michel C Nussenzweig
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.